Havey Adam
CIK 0001514588 Name as filed on the most recent filing
Filed as Havey Adam (22)
36 transaction lines · from 22 filings · filed 2011-03-15 to 2021-03-03 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
36 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2021-03-01 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 20,145 disposed | 99.02 | 1,994,757.90 | Form 4, filing 0001367644-21-000049 | |
| 2021-03-01 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 17,134 disposed | 99.62 | 1,706,889.08 | Form 4, filing 0001367644-21-000049 | |
| 2020-04-20 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 17,009 disposed | 69.00 | 1,173,621.00 | Form 4, filing 0001367644-20-000037 | |
| 2020-04-17 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 20,414 disposed | 65.00 | 1,326,910.00 | Form 4, filing 0001367644-20-000037 | |
| 2020-04-06 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 4,242 disposed | 60.00 | 254,520.00 | Form 4, filing 0001367644-20-000035 | |
| 2020-04-06 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 3,730 disposed | 60.00 | 223,800.00 | Form 4, filing 0001367644-20-000035 | |
| 2019-03-11 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 2,430 disposed | 56.93 | 138,339.90 | Form 4, filing 0001567619-19-006788 | |
| 2019-03-01 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 2,024 disposed | 58.20 | 117,796.80 | Form 4, filing 0001567619-19-006067 | |
| 2019-02-28 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 1,019 disposed | 57.92 | 59,022.31 | Form 4, filing 0001567619-19-006067 | |
| 2018-11-02 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 6,168 disposed | 64.50 | 397,836.00 | Form 4, filing 0001567619-18-005093 | |
| 2018-11-01 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 2,011 disposed | 63.50 | 127,698.50 | Form 4, filing 0001567619-18-005093 | |
| 2018-10-17 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 314 disposed | 63.50 | 19,939.00 | Form 4, filing 0001567619-18-004474 | |
| 2018-10-17 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 314 disposed | 61.50 | 19,311.00 | Form 4, filing 0001567619-18-004358 | |
| 2018-10-16 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 6,165 disposed | 61.50 | 379,147.50 | Form 4, filing 0001567619-18-004223 | |
| 2018-10-16 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 3,840 disposed | 63.50 | 243,840.00 | Form 4, filing 0001567619-18-004223 | |
| 2018-10-15 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 6,165 disposed | 60.15 | 370,854.96 | Form 4, filing 0001567619-18-004223 | |
| 2018-10-15 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 6,165 disposed | 60.03 | 370,080.63 | Form 4, filing 0001567619-18-004223 | |
| 2018-10-15 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 661 disposed | 60.67 | 40,102.87 | Form 4, filing 0001567619-18-004223 | |
| 2018-03-12 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 5,842 disposed | 52.82 | 308,574.44 | Form 4, filing 0001140361-18-013317 | |
| 2018-03-01 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 1,898 disposed | 49.50 | 93,951.00 | Form 4, filing 0001140361-18-011285 | |
| 2017-09-27 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 7,885 disposed | 39.50 | 311,457.50 | Form 4, filing 0001140361-17-036981 | |
| 2017-09-08 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 7,885 disposed | 37.06 | 292,242.54 | Form 4, filing 0001140361-17-035190 | |
| 2017-04-03 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 11,419 disposed | 28.62 | 326,808.35 | Form 4, filing 0001140361-17-014647 | |
| 2017-01-17 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 8,438 disposed | 29.75 | 251,000.97 | Form 4, filing 0001140361-17-002340 | |
| 2016-03-14 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 2,701 disposed | 33.96 | 91,725.96 | Form 4, filing 0001140361-16-058008 | |
| 2016-03-14 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 1,658 disposed | 33.96 | 56,305.68 | Form 4, filing 0001140361-16-058008 | |
| 2016-03-11 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 7,960 disposed | 33.84 | 269,366.40 | Form 4, filing 0001140361-16-057803 | |
| 2016-03-11 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 3,152 disposed | 33.84 | 106,663.68 | Form 4, filing 0001140361-16-057803 | |
| 2015-06-15 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 15,919 disposed | 31.50 | 501,480.34 | Form 4, filing 0001140361-15-024569 | |
| 2015-06-15 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 10,606 disposed | 31.50 | 334,110.21 | Form 4, filing 0001140361-15-024569 | |
| 2015-06-15 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 9,773 disposed | 31.66 | 309,462.04 | Form 4, filing 0001140361-15-024569 | |
| 2015-06-01 |
Emergent BioSolutions Inc. EBS |
P, Open-market purchase | 98 acquired | 27.08 | 2,653.84 | Form 4, filing 0001140361-15-022847 | |
| 2014-03-12 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 11,562 disposed | 27.50 | 317,955.00 | Form 4, filing 0001140361-14-012591 | |
| 2014-03-11 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 11,820 disposed | 26.96 | 318,667.20 | Form 4, filing 0001140361-14-012346 | |
| 2014-03-11 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 5,835 disposed | 26.96 | 157,311.60 | Form 4, filing 0001140361-14-012346 | |
| 2011-03-11 |
Emergent BioSolutions Inc. EBS |
S, Open-market sale | 6,667 disposed | 19.20 | 128,006.40 | Form 4, filing 0001209191-11-017975 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 1
- Open-market sale 35
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Havey Adam, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001514588
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6